RHUMBLINE ADVISERS - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 147 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$2,314,000
+55.0%
67,157
-24.8%
0.00%
+100.0%
Q2 2020$1,493,000
+33.3%
89,327
+15.0%
0.00%0.0%
Q1 2020$1,120,000
-51.4%
77,674
+12.8%
0.00%
-50.0%
Q4 2019$2,304,000
+72.2%
68,831
+7.7%
0.00%
+100.0%
Q3 2019$1,338,000
+1.3%
63,890
+0.7%
0.00%0.0%
Q2 2019$1,321,000
+2.9%
63,428
+10.4%
0.00%0.0%
Q1 2019$1,284,000
-7.4%
57,453
-0.9%
0.00%
-33.3%
Q4 2018$1,386,000
+30.1%
57,947
+48.5%
0.00%
+50.0%
Q3 2018$1,065,000
-5.1%
39,031
-6.5%
0.00%0.0%
Q2 2018$1,122,000
+5.6%
41,731
+25.0%
0.00%0.0%
Q1 2018$1,063,000
-17.0%
33,383
-1.4%
0.00%
-33.3%
Q4 2017$1,281,000
+28.7%
33,863
-15.7%
0.00%
+50.0%
Q3 2017$995,000
+22.4%
40,150
+1.5%
0.00%0.0%
Q2 2017$813,000
+26.2%
39,560
+33.5%
0.00%0.0%
Q1 2017$644,000
+9.9%
29,632
+3.5%
0.00%
+100.0%
Q4 2016$586,000
+52.6%
28,637
+11.8%
0.00%0.0%
Q3 2016$384,000
+67.7%
25,607
+20.8%
0.00%0.0%
Q2 2016$229,000
+57.9%
21,200
+98.5%
0.00%
Q1 2016$145,00010,6800.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 3,300,797$90,046,00033.32%
Aisling Capital LLC 1,990,000$54,287,00011.73%
Foresite Capital Management III, LLC 801,240$21,858,0004.82%
PACIFIC VIEW ASSET MANAGEMENT, LLC 189,857$5,181,0004.12%
AlpInvest Partners B.V. 38,943$1,062,0002.27%
Eventide Asset Management 1,739,000$47,440,0001.74%
Palo Alto Investors LP 1,381,759$37,694,0001.52%
Sofinnova Investments, Inc. 222,295$6,064,0000.54%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 553,000$15,086,0000.54%
EMERALD ADVISERS, LLC 486,666$13,276,0000.49%
View complete list of AIMMUNE THERAPEUTICS INC shareholders